A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Clinical trial NCT06481306 · RECRUITING

Trial details

NCT number: NCT06481306
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anemia, Sickle Cell Healthy Volunteers

Start date: 2024-07-17
Primary completion: 2027-01-06
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.